Join
Live feed
·
INSIDERFilingvia Quantisnow
Adial Pharmaceuticals Inc logo

SEC Form 4: Newman James W. Jr. bought $67,300 worth of shares (25,000 units at $2.69), increasing direct ownership by 100% to 20,000 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADIL (Adial Pharmaceuticals Inc) and more on Quantisnow.